Clinical Trial Update: A Study of BGM0504 in Overweight or Obese Participants [Phase 1]

View source ↗

Summary

Phase 1 study of BGM0504 in overweight or obese participants has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Drugs mentioned

• BGM0504

Snippet

Sponsor: BrightGene Bio-Medical Technology Co., Ltd. | Conditions: Overweight or Obese | Phase 1 | Status: COMPLETED